COMMUNIQUÉS West-GlobeNewswire

Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer
26/08/2026
If approved, REVTORPYK would be the first and only therapy for advanced breast cancer with a PIK3CA mutation that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 MINNEAPOLIS, Aug. 26 [...]
HepaRegeniX Receives Orphan Drug Designation for Darizmetinib for the Prevention of Post-Hepatectomy Liver Failure
26/08/2026
U.S. FDA Orphan Drug Designation underscores darizmetinib’s potential to address a significant unmet need following liver resection Tuebingen, Germany, August 26, 2026 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical- [...]
Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition
26/08/2026
NBI-1117567 is an investigational oral, muscarinic M1 preferring (M1/M4) selective agonist discovered by Nxera and advancing through clinical development under a multi-program collaboration with Neurocrine Nxera to [...]
4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing
26/08/2026
Commercial collaboration combines 4basebio’s synthetic DNA technology with Genezen’s viral vector development and manufacturing expertise to support gene therapy programs from early development through clinical and [...]
ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027
26/08/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, August 26, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
Testie Health Launches Nationwide to Make STI Testing Simpler, Faster, and Less Stigmatized
26/08/2026
New York, NY, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Testie Health , a consumer health company focused on making routine STI testing easier and less stigmatized, launches nationwide with a direct-to-lab testing model [...]
Celularity Provides Update Regarding Nasdaq Listing Compliance
26/08/2026
FLORHAM PARK, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”) today announced that, on August 21, 2026, it received a notification letter from the Listing Qualifications Department [...]
SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
26/08/2026
JERSEY CITY, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX), a clinical-stage biotechnology company focused on developing innovative therapies for severe and difficult-to-treat diseases with [...]
JATT III Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
26/08/2026
WESTFIELD, N. J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- JATT III Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the [...]
University of Miami's Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science
25/08/2026
MAPS provided the first outside funding for the University of Miami ibogaine research program in the 1990s The 1994 IND is not a substitute for current safety and sourcing data Earlier this summer, MAPS published its [...]
Perceptra, a Thai Startup, Brings Medical AI to International Markets to Enhance Regional Patient Screening
25/08/2026
Inspectra Drives Healthcare Innovation in Southeast Asia Singapore, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Perceptra Co., Ltd., a Thai startup developing artificial intelligence technology for medical image analysis, has [...]
VapoCept Capsule Label Guide: What the Supplement Facts Panel, Serving Directions, and Safety Statements Disclose for 2026
25/08/2026
L-Arginine, L-Citrulline, Niacin, and Beta-Alanine amounts, nitric oxide pathway sourcing, and manufacturing standards behind VapoCept's amino acid formula. Ogden, UT, Aug. 25, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Information on the total number of voting rights and shares
25/08/2026
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), August 25, 2026 , 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the [...]
Informations sur le nombre total de droits de vote et d'actions
25/08/2026
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 25 aout 2026, 22h30 CET / 16h30 ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
25/08/2026
NOVATO, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]
Voting Rights and Shares Capital of the Company
25/08/2026
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Aug. 25, 2026 (GLOBE NEWSWIRE [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
25/08/2026
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 25 août 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026
25/08/2026
PETACH TIKVA, Israel, Aug. 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial [...]
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
25/08/2026
GLEN ALLEN, Va., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee has granted a new employee stock option [...]

Pages